Enbrel Tuberculosis Risk
Enbrel Black Box Warning. Enbrel, a drug used to treat psoriasis that has been associated with serious infections, including tuberculosis in some patients. Enbrel's labeling will now carry the Food & Drug Administration's (FDA) strictest safety notice, a black box warning. Enbrel, manufactured by Amgen and Wyeth, is made from … [Read more...]
Avandia Heart Attack Risk Warning
Avandia Black Box Warning. An Avandia black box warning about its potential to cause heart attacks could soon appear on the drug’s label if officials at the Food & Drug Administration (FDA) have their way. The FDA is said to be pushing hard for the black box warning, the FDA’s strictest, to be including on Avandia’s label regarding … [Read more...]
FDA Black Box Warning for Ritalin and Other ADHD Drugs
ADHD Drugs Black Box Warning. In what many experts are viewing as an unusual turn of events, an FDA advisory panel has voted to recommend that the agency order the inclusion of the most serious “black box” warning on all stimulant ADHD medications due to evidence of a potential risk of heart attacks, strokes, and sudden death. The … [Read more...]
FDA Recommends ‘Black Box’ Warning for Ritalin, Adderall, Concerta, and Other ADHD Drugs
FDA Calls For A Black Box Warning For All ADHD Drugs. In what many experts are viewing as an unusual turn of events, an FDA advisory panel has voted to recommend that the agency order the inclusion of the most serious “black box” warning on all stimulant ADHD medications due to evidence of a potential risk of heart attacks, strokes, … [Read more...]
Feds Recommend Warnings on ADHD Drugs
FDA Recommend A Black Box Warning To ADHD Drugs. Federal science advisers voted narrowly Thursday to recommend the most serious type of warning labels for Ritalin and other stimulants that are used to treat attention deficit hyperactivity disorder. The 8-7 vote, with one abstention, by the Food and Drug Administration committee … [Read more...]
Cafergot Gets Warning
Cafergot Gets A New Black Box Warning From The U.S. FDA. FDA and Novartis strengthened the labeling, including a new BOXED WARNING and updates to the CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, and CLINICAL PHARMACOLOGY sections of the prescribing information for ‘Cafergot’. Serious and/or life-threatening peripheral ischemia has … [Read more...]
